Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

clinical trial

Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT00041938

P6099clinical trial phasephase III clinical trialQ42824827
P17countryCanadaQ16
United States of AmericaQ30
P582end time2011-08-01
P921main subjectacute myocardial infarctionQ18558122
P1050medical conditionmyocardial infarctionQ12152
coronary artery diseaseQ844935
P2899minimum age18
P1132number of participants2305
P6153research siteUniversity of North Carolina at Chapel HillQ192334
McGill UniversityQ201492
George Washington UniversityQ432637
University of ArizonaQ503419
Yeshiva UniversityQ1048851
University of LouisvilleQ1317143
University of KentuckyQ1360303
Louisiana State UniversityQ1521725
State University of New York at AlbanyQ1780816
Columbia University Irving Medical CenterQ2415975
Denver Health Medical CenterQ3023367
St. Michael's HospitalQ3145237
Montreal Heart InstituteQ3151984
University of Medicine and Dentistry of New JerseyQ3551717
Lahey ClinicQ6473221
Lehigh Valley HospitalQ6518847
Long Island Jewish Medical CenterQ6672700
Queen Elizabeth II Health Sciences Centre - Victoria GeneralQ7270360
Saint John Regional HospitalQ14875635
MetroHealth Medical CenterQ30254005
Temple University HospitalQ30254036
William S. Middleton Memorial Veterans HospitalQ30281170
P1813short nameWARCEF
P580start time2002-10-01
P8363study typeinterventional studyQ78089383
P1476titleWarfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

Search more.